Invention Grant
- Patent Title: Canine autologous immunotherapy using dendritic cell induced cancer killing immunocytes
-
Application No.: US16044347Application Date: 2018-07-24
-
Publication No.: US10716810B2Publication Date: 2020-07-21
- Inventor: Thomas Ichim , David Koos
- Applicant: Zander Therapeutics, Inc.
- Applicant Address: US CA La Mesa
- Assignee: Zander Therapeutics, Inc.
- Current Assignee: Zander Therapeutics, Inc.
- Current Assignee Address: US CA La Mesa
- Agency: Baumgartner Patent Law
- Agent Marc Baumgartner
- Main IPC: A61K35/17
- IPC: A61K35/17 ; C12N5/0784 ; A61K39/00 ; C12N5/0783

Abstract:
Described are compositions of matter, protocols, and treatment means for induction of immune mediated killing in dogs suffering from cancer. The invention provides means of extracting peripheral blood from a canine patient, expanding immunocytes capable of killing cancer cells in vitro, and re-administering said immunocytes into a patient in need of therapy. In one embodiment, immunocytes expanded are T cells possessing tumor cytotoxic activity induced by stimulation of NKG2D.
Public/Granted literature
- US20190000879A1 CANINE AUTOLOGOUS IMMUNOTHERAPY USING DENDRITIC CELL INDUCED CANCER KILLING IMMUNOCYTES Public/Granted day:2019-01-03
Information query
IPC分类: